Cost-Effectiveness of the Addition of Rituximab to CHOP Chemotherapy in First-Line Treatment for Diffuse Large B-Cell Lymphoma in a Population-Based Observational Cohort in British Columbia, Canada

Author: Johnston Karissa M.   Marra Carlo A.   Connors Joseph M.   Najafzadeh Mehdi   Sehn Laurie   Peacock Stuart J.  

Publisher: Blackwell Publishing

ISSN: 1098-3015

Source: Value in Health, Vol.13, Iss.6, 2010-09, pp. : 703-711

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract